HAUPPAUGE, N.Y., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the CE mark for ...
MEDFORD, N.Y., July 05, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received ...
HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious diseases, today announced it has been ...
HAUPPAUGE, N.Y., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has ...
HAUPPAUGE, N.Y., April 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a second $1.5 ...
Chembio Diagnostics Inc. Wednesday announced plans to sell a new reader with some of its rapid medical tests. The Medford-based manufacturer of point-of-care tests for HIV, Ebola, malaria and other ...
HAUPPAUGE, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that the U.S.
Chembio Diagnostics Inc. has received a $1.5 million order for its rapid tests for Zika from UNICEF, officials said Wednesday. The Medford manufacturer of point-of-care tests for HIV, syphilis, Ebola, ...
Good afternoon, ladies and gentlemen, and welcome to the Chembio Fourth Quarter 2020 Earnings Conference Call and Webcast. [Operator Instructions] It is now my pleasure to turn the floor over to your ...
* Chembio Diagnostics - Has received approval for commercial use in Brazil of DPP micro reader by ANVISA in collaboration with Bio-Manguinhos/Fiocruz Source text for Eikon: Further company coverage: U ...
HAUPPAUGE, N.Y., April 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a second $1.5 ...